Severe and refractory solar urticaria treated with intravenous immunoglobulins: A phase II multicenter study

Journal of the American Academy of Dermatology

Volumn 71, Issue 5, 2014, Pages 948-953.e1

  Aubin, François ^a   Porcher, Raphaël ^b   Jeanmougin, Michel ^b   Léonard, Fabienne ^c   Bedane, Christophe ^d   Moreau, Anne ^d   Schmutz, Jean Luc ^d   Marguery, Marie Claude ^d   Adamski, Henri ^e   Viguier, Manuelle ^b  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c REIMS UNIVERSITY HOSPITAL   (France)

^d NONE   (France)

^e SERVICE DE PNEUMOLOGIE   (France)

Author keywords

Adverse events; Aseptic meningitis; Headache; Intravenous immunoglobulins; Minimal urticarial dose; Phototesting; Side effects; Solar urticaria

Indexed keywords

IMMUNOGLOBULIN; IMMUNOLOGIC FACTOR;

ADULT; APHTHOUS STOMATITIS; ARTICLE; ASEPTIC MENINGITIS; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DYSHIDROSIS; ECZEMA; FEMALE; FOLLOW UP; HEADACHE; HOSPITALIZATION; HUMAN; MALE; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIASIS; QUALITY OF LIFE; REMISSION; SOLAR URTICARIA; TREATMENT DURATION; VISUAL ANALOG SCALE; ADVERSE EFFECTS; CLINICAL TRIAL; MIDDLE AGED; PHOTOSENSITIVITY DISORDERS; SEVERITY OF ILLNESS INDEX; SUNLIGHT; URTICARIA; YOUNG ADULT;

ADULT; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; PHOTOSENSITIVITY DISORDERS; PROSPECTIVE STUDIES; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SUNLIGHT; URTICARIA; YOUNG ADULT;

EID: 84922480068     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2014.07.023     Document Type: Article

References (20)

1. Beattie PE, Dawe RS, Ibbotson SH, Ferguson J. Characteristics and prognosis of idiopathic solar urticaria: a cohort of 87 cases. Arch Dermatol 2003;139:1149-54.
2. Horio T. Solar urticaria-idiopathic? Photodermatol Photoimmunol Photomed 2003;19:147-54.
3. Botto NC, Warshaw EM. Solar urticaria. J Am Acad Dermatol 2008;59:909-20.
4. Roelandts R. Diagnosis and treatment of solar urticaria. Dermatol Ther 2003;16:52-6.
5. Edström DW, Ros AM. Cyclosporin A therapy for severe solar urticaria. Photodermatol Photoimmunol Photomed 1997;13:61-3.
6. Bissonnette R, Buskard N, McLean DI, Lui H. Treatment of refractory solar urticaria with plasma exchange. J Cutan Med Surg 1999;3:236-8.
7. Mang R, Stege H, Budde MA, Ruzicka T, Krutmann J. Successful treatment of solar urticaria by extracorporeal photochemotherapy (photopheresis) ea case report. Photodermatol Photoimmunol Photomed 2002;18:196-8.
8. Guzelbey O, Ardelean E, Magerl M, Zuberbier T, Maurer M, Metz M. Successful treatment of solar urticaria with anti-immunoglobulin E therapy. Allergy 2008;63:1563-5.
9. Waibel KH, Reese DA, Hamilton RG, Devillez RL. Partial improvement of solar urticaria after omalizumab. J Allergy Clin Immunol 2010;125:490-1.
10. Adamski H, Bedane C, Bonnevalle A, Thomas P, Peyron JL, Rouchouse B, et al. Solar urticaria treated with intravenous immunoglobulins. J Am Acad Dermatol 2011;65:336-40.
11. Jeanmougin M, Civatte J. Dosimetry of solar ultraviolet radiation: daily and monthly changes in Paris [in French]. Ann Dermatol Venereol 1987;114:671-6.
12. A'Hern RP. Sample size tables for exact single-stage phase II designs. Stat Med 2011;20:859-66.
13. O'Donnell BF, Barr RM, Black AK, Francis DM, Kermani F, Niimi N, et al. Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol 1998;138:101-6.
14. Dawn G, Urcelay M, Ah-Weng A, O'Neill SM, Douglas WS. Effect of high-dose intravenous immunoglobulin in delayed pressure urticaria. Br J Dermatol 2003;149:836-40.
15. Correia I, Silva J, Filipe P, Gomes M. Solar urticaria treated successfully with intravenous high dose immunoglobulin: a case report. Photodermatol Photoimmunol Photomed 2008;24:330-1.
16. Hughes R, Cusack C, Murphy GM, Kirby B. Solar urticaria successfully treated with intravenous immunoglobulin. Clin Exp Dermatol 2009;34:e660-2.
17. Llamas-Velasco M, Argila DD, Eguren C, Garcia-Martin P, Ibanes S, Garcia-Diez A. Solar urticaria unresponsive to intravenous immunoglobulins. Photodermatol Photoimmunol Photomed 2011;27:53-4.
18. Sekul EA, Cupler EJ, Dalakas MC. Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors. Ann Intern Med 1994;121:259-64.
19. Feldmeyer L, Benden C, Haile SR, Boehler A, Speich R, French LE, et al. Not all intravenous immunoglobulin preparations are equally well tolerated. Acta Derm Venereol 2010;90:494-7.
20. Dhainaut F, Guillaumat PO, Dib H, Perret G, Sauger A, De Coupade C, et al. In vitro and in vivo properties differ among liquid intravenous immunoglobulin preparations. Vox Sang 2013;104:115-26.